Amplifyer Bio
Unlocking the full power of liquid biopsy
- Business Model
- B2B
- Website
- amplifyer.bio
About
Amplifyer Bio develops priming agents intended to improve the performance of existing liquid-biopsy diagnostics. Its first agent, AM-01, is a monoclonal antibody designed to bind cell-free DNA and temporarily protect it from clearance before a blood draw. The approach aims to increase tumor signal in blood samples so existing diagnostic platforms can deliver more reliable and actionable cancer-test results.
Summary
Amplifyer Bio is a Biotech company.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
Minneapolis-based clinical stage biotechnology company focused on the development of molecularly ...
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/amplifyer-bio"><img src="https://indexed.vc/api/badge/company/amplifyer-bio" alt="Amplifyer Bio on Indexed.vc" width="260" height="76" /></a>